Vimta Labs Quarterly Results for Trading Insights
VIMTALABS • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹15 Cr
QSept 2024
Vimta Labs Quarterly Results Key Highlights
- Revenue of ₹85 Cr in Sept 2024 (+6.2% vs Mar 2024, +25.0% vs Sept 2023)
- Net Profit of ₹15 Cr in Sept 2024 (+25.0% vs Mar 2024, +150.0% vs Sept 2023)
- EBITDA of ₹29 Cr in Sept 2024 (+16.0% vs Mar 2024)
- Operating Margin of 33.0% in Sept 2024 (+2.0pp vs Mar 2024)
- Earnings Per Share of ₹6.88 in Sept 2024 (+23.3% vs Mar 2024)
Vimta Labs Quarterly Results Analysis
| Metric | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 85 | 80 | 76 | 95 | 68 | 6.3% | 25.0% |
| Net Profit (₹ Cr) | 15 | 12 | 12 | 22 | 6 | - | - |
| EBITDA (₹ Cr) | 29 | 25 | 25 | 38 | 18 | - | - |
| EPS (₹) | 6.88 | 5.58 | 5.54 | 9.65 | 2.86 | - | - |
| Operating Margin (%) | 33.0% | 31.0% | 32.0% | 37.0% | 24.0% | - | - |
Vimta Labs Share Price Trend Around Quarterly Results
Visualize Vimta Labs's 1-year price movement across quarterly results — ideal for logging trades in Vimta Labs share price
chart using Tickjournal. All values in ₹.
Related Pages for Vimta Labs
Additional stock information and data for VIMTALABS
Revenue Trend (₹ Cr)
Dec 2024
95
Jun 2024
76
Mar 2024
80
Sept 2024
85
Net Profit Trend (₹ Cr)
Dec 2024
22
Jun 2024
12
Mar 2024
12
Sept 2024
15
Operating Margin Trend (%)
Dec 2024
37.0%
Jun 2024
32.0%
Mar 2024
31.0%
Sept 2024
33.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Vimta Labs quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1782.6 | 14,875 | 3,125 | +10.8% | - | 21.0% | 137.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 4092.2 | 3,219 | 591 | +11.3% | - | 18.4% | 233.3 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1467.9 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.7 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1242.8 | 9,135 | 1,337 | +1.1% | - | 14.6% | 76.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores